The UV research groups (GIUV) are regulated in the 1st chapter of the Regulation ACGUV48/2013, which explains the procedure for creating new research structures. They are basic research and organizational structures that result from the voluntary association of researchers that share objectives, facilities, resources and common lines of research. These researchers are also committed to the consolidation and stability of their activity, work in groups and the capability to achieve a sustainable funding.

The research groups included in the previously mentioned Regulation are registered in the Register of Research Structures of the Universitat de València (REIUV), managed by the Office of the Vice-principal for Research and Scientific Policies. The basic information of these organisms can be found in this website.

Participants

Data related to research groups featured in various information dissemination channels shall not, under any circumstances, imply a statement or commitment regarding the employment or academic affiliation of individuals associated with the Universitat de València. Their inclusion is solely the responsibility of the group directors. Updates will be made upon request from interested parties.

  • Registered groups in the Register of Research Structures of the Universitat de València - (REIUV)

Stroke Pathophysiology and Therapeutics Research group - NeurIctus

Reference of the Group:

GIUV2026-023

 
Description of research activity:
Our research activity focuses on the study of the cellular, molecular, and vascular processes involved in brain damage caused by stroke, with a translational approach aimed both at understanding the pathophysiology of cerebral ischemia and at developing new therapeutic strategies. The groups work addresses the analysis of the cascade of brain injury, neuroprotective processes, the search for therapies for stroke treatment, and the identification of peripheral biomarkers to improve diagnosis, stratification, and patient follow-up. All of this is pursued with the ultimate goal of identifying new therapeutic targets capable of protecting or repairing brain tissue after ischemic stroke and of contributing to improved functional outcomes for affected individuals. The groups main lines of research focus on evaluating, using animal models, the neuroprotective capacity of endogenous and exogenous substances, particularly Selective Estrogen Receptor Modulators (SERMs). In addition, the role of inflammation in cerebral ischemic pathology is studied, as well as cellular senescence as a potential therapeutic target in ischemic stroke through multi-omic approaches. This strategy opens the door...Our research activity focuses on the study of the cellular, molecular, and vascular processes involved in brain damage caused by stroke, with a translational approach aimed both at understanding the pathophysiology of cerebral ischemia and at developing new therapeutic strategies. The groups work addresses the analysis of the cascade of brain injury, neuroprotective processes, the search for therapies for stroke treatment, and the identification of peripheral biomarkers to improve diagnosis, stratification, and patient follow-up. All of this is pursued with the ultimate goal of identifying new therapeutic targets capable of protecting or repairing brain tissue after ischemic stroke and of contributing to improved functional outcomes for affected individuals. The groups main lines of research focus on evaluating, using animal models, the neuroprotective capacity of endogenous and exogenous substances, particularly Selective Estrogen Receptor Modulators (SERMs). In addition, the role of inflammation in cerebral ischemic pathology is studied, as well as cellular senescence as a potential therapeutic target in ischemic stroke through multi-omic approaches. This strategy opens the door to the development of senotherapeutic therapies as new tools for the treatment of this condition.
[Read more][Hide]
 
Web:

No determinada

 
Scientific-technical goals:
  • Development and evaluation of neuroprotective and neuroreparative strategies in animal models of stroke.
  • Multi-omic characterization of pathological processes associated with stroke.
  • Study of cellular senescence as a potential therapeutic target in stroke and development of senotherapeutic therapies.
  • Identification of peripheral biomarkers to improve diagnosis, stratification, and follow-up of stroke patients.
  • Study of the cellular, molecular, and vascular processes involved in brain damage after stroke.
 
Research lines:
  • Study of cellular and molecular mechanisms in cerebral ischemic pathophysiology.This line of research focuses on understanding the cellular and molecular processes that occur after an ischemic stroke, with the aim of identifying the mechanisms that contribute to neuronal damage, with special emphasis on neuroinflammatory processes and on the activation of associated pathological pathways.
  • Preclinical evaluation of neuroprotective strategies in stroke using animal models.This line of research focuses on the development and validation of neuroprotective drugs or therapies using animal models. Through these models, interventions capable of modulating the cellular and molecular mechanisms involved in post-stroke brain damage are investigated, contributing to a deeper understanding of stroke pathophysiology, as well as to the assessment of the biological impact of experimental therapies.
  • Multi-omic studies and search for plasma biomarkers of stroke.This line focuses on the use of multi-omic approaches (epigenomics, transcriptomics, and proteomics) for the study of stroke and the identification of peripheral biomarkers that can improve both diagnosis and the monitoring of therapeutic interventions. In particular, our aim is to characterize stroke-induced cellular senescence in order to understand its role in the progression of cerebral ischemic injury and to explore its potential as a target for the development of effective senotherapeutic strategies for the treatment of ischemic stroke.
 
Group members:
Name Nature of participation Entity Description
MARÍA CASTELLO RUIZDirectorUniversitat de València
Research team
ALICIA ALIENA VALEROMemberUniversitat de València
IRENE MARÍA ESCUDERO MARTÍNEZCollaboratorHospital Universitari i Politècnic La FePhisician
 
Associated structure:
  • Cellular Biology and Functional Biology
 
Keywords:
  • NEUROPROTECTION
  • ISCHAEMIC STROKE
  • NEURAL REPAIR
  • CEREBRAL PATHOPYSIOLOGY